Just two months after a PhD student at King Fahd University of Petroleum and Minerals in Saudi Arabia published a paper in August without the knowledge of his co-author, a professor at the university, the paper was retracted by Cellulose.
A dentistry journal has retracted a paper after discovering the research was lifted from dissertation work by two people unrelated to the paper authors.
A mistake in structure identification has sunk a paper by researchers at the NIH, MIT, and Seoul National University in the Cell Press journal Chemistry and Biology.
Ludwigshafen Hospital, via Wikimedia http://commons.wikimedia.org/wiki/File:Klinikum_Ludwigshafen_Nordseite.jpg
Update, 4 p.m. EST, 10/29/14: As a commenter points out, we didn’t quite get this one right. The Boldt paper that has been retracted was not previously retracted for lack of IRB approval. Rather, it was a heretofore unretracted article, from 1996, which German investigators have determined contained faked data. We’ve made edits below using strikethroughs, and have changed the headline to better reflect the content. We apologize for the errors.
We’ve commented before on the fact that we’ve noticed there’s often more to retractions whose stated reason is lack of institutional review board (IRB) approval. We can understand editors’ inclination to act as quickly as possible to issue a retraction, the scientific publishing equivalent of jailing Al Capone for tax evasion. But we appreciate it even more when said editors return to the scene of the crime, as it were, when new important details come out.
Case in point: Anesthesia & Analgesia has amended its retraction of a 2009 1996 study by Joachim Boldt — who with nearly 90 retractions once held the record in that department — based on findings that the data in that paper were fabricated.
The article was titled “Cardiopulmonary bypass priming using a high dose of a balanced hydroxyethyl starch versus an albumin-based priming strategy,” “The effects of albumin versus hydroxyethyl starch solution on cardiorespiratory and circulatory variables in critically ill patient.” had previously been retracted because Boldt had failed to obtain adequate ethics approval for the research. But now comes this, According to the retraction notice from editor in chief Steven Shafer: Continue reading Boldt’s data were fake in 1996 paper
A math paper in the Journal of Inequalities and Applications has been retracted after it was discovered the authors had included a student’s work without acknowledging her.
One of the authors, however, told us it was an honest mistake, and that the editor pushed for retraction instead of correction “to protect this journal and its impact factor.”
A cardiovascular group has retracted a conference proceeding abstract, because it too closely resembled a paper they published prior to the conference.
The last author is baffled as to why the journal couldn’t have made that call before they published the abstract.
In June, a paper in Tumor Biology was retracted for at least four reasons, including bad data and hiding a trial sponsor (Merck). Some people who contributed work weren’t cited; at least one author had no idea his name would be on it. And that’s just what they tell us in the notice.
PubPeer leads the way again: The authors of a paper about Parkinson’s disease in the Proceedings of the National Academy of Sciences (PNAS) have retracted it, several months after a commenter highlighted the exact issue that led to the article’s demise.